Icure Pharmaceutical Incorporation (KOSDAQ:175250)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,170.00
+231.00 (11.91%)
At close: Aug 5, 2025
Market Cap81.09B -2.0%
Revenue (ttm)93.22B +53.8%
Net Income-31.47B
EPS-853.46
Shares Out37.37M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,019,275
Average Volume246,304
Open2,050.00
Previous Close1,939.00
Day's Range1,955.00 - 2,255.00
52-Week Range1,399.00 - 2,980.00
Beta0.40
RSI64.65
Earnings DateMar 20, 2026

About KOSDAQ:175250

Icure Pharmaceutical Incorporation, a biopharmaceutical company, researches, develops, and sells pharmaceutical and cosmetic products in South Korea. The company offers functional, nature-derived, derma, and customized cosmetics products. It also offers eye gel, hydro nude gel, lip gel mask, and functional patch products; and sheet, mud, foil, and melting masks. In addition, the company provides body and haircare products, including naturally derived hair and baby line, cleansing tissue, and wet wipes. Further, it offers perfumes, textile perfu... [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations
Founded 2000
Employees 220
Stock Exchange KOSDAQ
Ticker Symbol 175250
Full Company Profile

Financial Performance

Financial Statements